博士眼鏡(300622.SZ)擬向銀行申請不超2.5億元綜合授信額度
格隆匯3月31日丨博士眼鏡(300622.SZ)公佈,公司於2020年3月31日召開第三屆董事會第二十一次會議,審議通過了《關於申請銀行授信的議案》。
為滿足公司經營需要,綜合考慮公司資金安排,公司向相關銀行申請不超過人民幣2.5億元的綜合授信額度。上述授信總額不等於公司實際融資金額,實際融資金額以在授信額度內各家銀行與公司(全資子公司及控股子公司)實際發生的融資金額為準。在授信總額範圍內,公司管理層可根據公司實際資金需求調整各銀行間的授信額度。
公司授權公司董事長代表公司簽署上述授信事項下的相關法律文件。由此產生的法律、經濟責任由公司承擔。上述綜合授信額度及授權期限自董事會審議通過之日起12個月內有效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.